The Engine Ventures — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Foray BioscienceFeb 2024
Protecting and restoring natural ecosystems, one plant cell at a time.
BiotechCambridge, US
Ashley Beckwith(Executive Officer, Director)
Kano Therapeuticskanotherapeutics.comin𝕏May 2024
Kano Therapeutics is a biotech company developing chemical biology platforms aimed at clinical and commercial therapeutic products.
BiotechCambridge, US
Floris Engelhardt(Executive Officer, Director)John Vroom(Director)
BoardAnn DeWitt(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.